$SENS Pharma Runner A/H: Senseonics' Eversense Shows Positive Performance Over Multiple Sensor Tests - Stock Higher After-Hours
05:49 PM EST, 11/21/2019 (MT Newswires) -- Senseonics Holdings(SENS) said on Thursday data from 945 adult users showed that the performance of its Eversense sensor over four sensor cycles is stable and does not decrease over time and there was no degradation of patient glucose outcomes over the four sensor cycles.
"This large real-world data set supports the clinical relevance and accuracy of the Eversense system to the healthcare provider and payer communities as we seek further expansion of coverage for Eversense as a clinically-proven choice for CGM therapy," said medical head Francine Kaufman.
"...You may all go to hell and I will go to Texas." ~ Davy Crockett, 08-11-1835